Thursday, August 20, 2026 See who Washington just made rich Go Pro · $40/mo →
Money Racket
Who Cashes In When Washington Moves
ENERGYNewsom Passes Diablo Canyon Decision to SuccessortodayDEFENSEPentagon's $80M Drone Defense Contract Points to the Counter-UAS Names Worth Watching4 weeks agoDEFENSERTX Lands Fresh Missile Defense Contract—Stock UndervaluedyesterdayDEFENSEU.S.-Iran Conflict Escalation Stalls Hormuz Shipping — Defense Contractors and Oil Majors Are the Immediate Read4 weeks agoTECHCommerce Eases Drone Export Rules—U.S. Makers WinyesterdayWHITE HOUSETrump's Defense Supply Chain Order Tightens Waiver Rules — Domestic Parts Makers Win, Foreign-Sourced Primes Face Friction4 weeks agoHEALTHCARE & FDAFDA Reclassifies Cancer Tests—Easier Path for Diagnostics2 days agoENERGYNew Jersey's Nuclear Energy Law Opens a Real Revenue Path for Small Reactor Developers4 weeks agoHEALTHCARE & FDAFTC Probes Epic Systems Over Health Records Monopoly2 days agoENERGYTrump's Saudi Nuclear Pact Without Enrichment Safeguards Heads to Congress — U.S. Uranium and Nuclear Services Names Are the Play4 weeks agoDEFENSETrump's $1.5T Defense Push Fuels Colorado Contractor Windfall2 days agoWHITE HOUSETrump's Critical Minerals Order Cuts China Out of the Defense Supply Chain — and Sends Money to U.S. Miners4 weeks agoENERGYEPA Exempts Calcium Carbonate From Pesticide Tolerance—Farm Input Eases2 days agoCRYPTOWhite House Concedes Ethics Provision in Crypto Bill — Clearing the Last Roadblock for Stablecoin Legislation4 weeks agoWHITE HOUSETrump Vaccine Spacing Order Reshapes Pharma Demand3 days agoHEALTHCARE & FDACMS Freezes $1 Billion in Medicaid Payments to California and Minnesota — Managed Care Insurers Face Revenue Gaps4 weeks agoHEALTHCARE & FDACMS Ends Medicare Part D Subsidy—Insurers Face Pressure3 days agoTECHBosch's $225M CHIPS Act Award for Roseville Chips Away at U.S. Dependence on Asian Auto Semiconductors4 weeks agoTRADE & TARIFFSTariff Refunds Flow to Retailers—Earnings Boost3 days agoENERGYNRC Approves Holtec's Upgraded Spent Fuel Storage System — A Quiet Win for Nuclear's Capacity Expansion4 weeks agoENERGYArmy Corps Permits Line 5 Tunnel—Michigan Blocks Path4 days agoDEFENSEHouse Passes $1.15T Defense Bill — Missile Defense, Shipbuilding, and Next-Gen Air Get the Money4 weeks agoTRADE & TARIFFSTariff Refunds Turbocharge Retailer Earnings4 days agoTRADE & TARIFFSTrump's 50% Canada Tariff Threat Keeps U.S. Aluminum Tight — Domestic Producers Win, Manufacturers Pay4 weeks agoCRYPTOSEC Delays Crypto Rules—Uncertainty Persists5 days agoDEFENSEOracle Lands a $7B Pentagon Software Contract — and the Market Should Take It Seriously4 weeks agoTRADE & TARIFFSKimberly-Clark Pockets $45M Tariff Refund5 days agoENERGYTrump Signs the Saudi Nuclear Deal — and U.S. Uranium and Reactor Companies Are the Quiet Winners4 weeks agoTRADE & TARIFFSTrump Tariffs on Drones Boost U.S. Makers5 days agoWHITE HOUSETrump's Critical Minerals Order Cuts China Out of the Military Supply Chain — These Miners Fill the Gap4 weeks agoHEALTHCARE & FDASimparica Trio Gets Screwworm EUA—Zoetis Wins6 days agoCRYPTOThe Senate's Landmark Crypto Bill Creates Winners Inside the ETF and Exchange Stack4 weeks agoDEFENSEBlackSky Lands Multi-Year Satellite Contract6 days agoDEFENSEThe U.S.-Iran War Is Costing $37.5B and Counting — Here's Where That Money Goes4 weeks agoTECHFCC Eases Broadband Label Rules—ISPs Win Flexibilitylast weekHEALTHCARE & FDACMS's Star Ratings Overhaul Rescues the Biggest Medicare Advantage Insurers — For Now4 weeks agoDEFENSEIonQ Lands $28M U.S. Defense Quantum Contractlast weekTRADE & TARIFFSTariffs on Indian Pharma Are Coming — and U.S. Generic Drug Buyers Will Pay the Bill4 weeks agoHEALTHCARE & FDAFDA Clears Screwworm Prevention Drug for U.S. Livestocklast weekMARKETSChina's $765M Antitrust Fine on Trip.com Is a Warning Shot for U.S.-Listed Chinese Consumer Stocks4 weeks agoENERGYNRC Approves NAC MAGNASTOR Spent Fuel Storage Casklast weekDEFENSEPentagon's $7B Oracle Software Deal Is One of the Cleanest Defense-Tech Wins in Years4 weeks agoHEALTHCARE & FDAFDA Updates Fresh-Cut Produce Safety Guidancelast weekDEFENSEPentagon Awards Oracle $7B Software Consolidation Deal—Direct Win for Oracle, Pressure on Smaller Defense IT Rivals3 weeks agoWHITE HOUSETrump Orders Childhood Vaccine Schedule Spacinglast weekTECHFCC Tightens Submarine Cable Licensing Rules—Tech Giants Face New Compliance Costs, Telecom Carriers Gain Regulatory Clarity3 weeks agoWHITE HOUSETrump Order Splits MMR Vaccine—Pharma Faces Demand Shiftlast weekHEALTHCARE & FDACMS Overhauls Medicare Advantage Star Ratings—UnitedHealth, Humana, and Anthem Positioned to Gain from Simplified Metrics3 weeks agoDEFENSETrump Pushes $1.5T Defense Budget—Lockheed, RTX, GD Lock in Gainslast weekDEFENSEHouse Passes $1.15 Trillion Defense Bill—Lockheed, Raytheon, and General Dynamics Positioned for Record Spending3 weeks agoWHITE HOUSEWhite House Drafts Vaccine-Autism Order—Pharma Faces Uncertaintylast weekDEFENSEPentagon Awards Oracle $7B Software Consolidation Deal—Largest Defense IT Overhaul in Years3 weeks agoTECHTrump Administration Adds 6 Chipmakers to U.S. Portfoliolast weekDEFENSERocket Lab Wins $266M Space Force Contract—Suborbital Launch Capability Becomes Defense Asset3 weeks agoDEFENSEPentagon Awards Space-Based Target Tracking Contractslast weekHEALTHCARE & FDACMS Overhauls Medicare Advantage Star Ratings—Big Insurers Win, Quality Metrics Tighten3 weeks agoENERGYMichigan Court Rejects Enbridge Line 5 Permit Under Great Lakeslast weekDEFENSERocket Lab Wins $266M Space Force Missile Defense Contract—Suborbital Launch Niche Gets Federal Validation3 weeks agoWHITE HOUSEDHS Tightens H-1B/L-1 Visa Fees—Tech Hiring Costs Rise for Employerslast weekDEFENSEPentagon Awards Oracle $7B Software Consolidation Deal—Cloud Incumbents Face Pressure, Oracle Locks in Defense Revenue3 weeks agoTECHU.S. Signs $874M Semiconductor Research LOIs—Chip Makers Get Federal Backinglast weekCRYPTOSEC Settles Coinbase FOIA Suit Over Missing Gensler Texts—Crypto Compliance Pressure Eases, Coinbase Stock Gains Clarity3 weeks agoTRADE & TARIFFSRetailers Sell Off Tariff Refund Rights for Cash—Windfall Monetized Before Payoutlast weekHEALTHCARE & FDACMS Stars Redo Lifts Medicare Advantage Insurers—Rating System Overhaul Favors UnitedHealth, Humana, Anthem3 weeks agoHEALTHCARE & FDAFDA Approves Tudriqev for Advanced Melanomalast weekDEFENSEPentagon Awards Largest F-35 Spare Parts Contract—Lockheed Locks in Sustainment Revenue3 weeks agoHEALTHCARE & FDAFTC Sues Hims & Hers Over Privacy and Billing Practices2 weeks agoDEFENSEHouse Passes $1.15T Defense Bill—Lockheed, Raytheon, General Dynamics Lock in Revenue3 weeks agoMARKETSFTC Threatens Booking Holdings Over Priceline Practices2 weeks agoMARKETSSEC Explores 23-Hour Stock Trading—Market Makers and Tech Platforms Get New Revenue3 weeks agoDEFENSERising Defense Spending Lifts Northrop Grumman Outlook2 weeks agoENERGYPHMSA Updates Pipeline Safety Standards—Compliance Costs Hit Operators, Benefit Inspectors3 weeks agoTRADE & TARIFFSTrump Administration Hits $100B Tariff Refund Milestone2 weeks agoSEARCH DEMANDCasgevy List Price: $2.2 Million3 weeks agoHEALTHCARE & FDACMS Raises IRF Payments for 2027—Rehab Hospitals Get Relief2 weeks agoSEARCH DEMANDData Center Power Exchange3 weeks agoHEALTHCARE & FDACMS Ends Medicare Part D Subsidy—Drug Plan Insurers Face Margin Pressure2 weeks agoTRADE & TARIFFSAmazon Gets $600M Tariff Refund—Retailers Lift Guidance on Windfall3 weeks agoHEALTHCARE & FDAHHS Boosts Hospital Payments by $2 Billion—Acute Care Operators Win2 weeks agoTECHCommerce Awards $874M in Semiconductor R&D LOIs—Chip Makers Get Federal Backing3 weeks agoTRADE & TARIFFSAmazon Pockets $600M Tariff Refund—Retail Rivals Face Margin Squeeze2 weeks agoHEALTHCARE & FDAFDA Revokes Petroleum-Based Food Dyes—Natural Color Makers Win3 weeks agoENERGYMichigan Court Vacates Line 5 Permit—Enbridge Faces Shutdown Risk2 weeks agoDEFENSEHouse Passes $95B Iran War Package—Defense Contractors Lock in Revenue3 weeks agoHEALTHCARE & FDAHumana Exits MA Markets—600K Members Face Plan Disruption3 weeks agoWHITE HOUSETrump Blocks Critical Minerals Exports—U.S. Miners Get Protected Market3 weeks ago
1 free article left this week. A free account gets you 4 a week.Go Pro →
Healthcare & FDA

Medicare Starts Covering Obesity Drugs — Novo Nordisk and Eli Lilly Just Got 67 Million New Potential Customers

CMS coverage of GLP-1s for obesity is the single largest demand expansion in the history of the drug class.

Image: Money Racket
By at Money Racket · Jul 11, 2026
1-YEAR MOVE
+45% −37%
NVO ▼14.3% LLY ▲43.0% UNH ▲20.3%
1-year price move by ticker
TickerCompany1-year change
NVONovo Nordisk−14.3%
LLYEli Lilly+43.0%
UNHUnitedHealth+20.3%

Medicare will begin covering GLP-1 obesity drugs for the first time, with a bridge program already launched for qualifying patients. The coverage applies to beneficiaries meeting specific clinical criteria, and the full rollout is expected to reach tens of millions of eligible Medicare enrollees.

Medicare covering obesity drugs isn't a policy footnote — it's the largest single demand expansion the GLP-1 market has ever seen, and Novo and Lilly have the only products that qualify.

Who cashes in: Novo Nordisk NVO and Eli Lilly LLY are the direct and overwhelming winners — they make Wegovy/Ozempic and Zepbound/Mounjaro respectively, the only GLP-1s with obesity indications. Medicare's 67 million beneficiaries represent a demand pool that dwarfs what commercial insurance has unlocked so far. The constraint is manufacturing capacity, not demand, so both companies benefit roughly in proportion to their production ramp. Specialty pharmacy distributors like Cencora COR and McKesson MCK benefit from higher-cost drug volumes flowing through their networks. On the device side, companies selling continuous glucose monitors and insulin pumps face long-term displacement as GLP-1s reduce diabetes severity.

Who's exposed: Medicare Advantage insurers — UnitedHealth UNH, Humana HUM, Elevance ELV, and CVS Health CVS through Aetna — face the most direct cost pressure. GLP-1s run $10,000-$15,000 per patient per year at list price. Even with rebates, covering millions of obese Medicare beneficiaries is a material claims cost increase. Humana is particularly exposed given its heavy Medicare Advantage concentration. The stars-rating and bonus payment system means insurers can't easily exclude the drugs without quality score consequences.

What to watch next: The specific formulary placement and prior authorization requirements CMS sets will determine actual utilization. Watch for the final CMS rule on GLP-1 coverage criteria — the gap between "covered" and "accessible" is where insurer margins and pharma revenues actually get set.

Source: original report ↗

Free alerts

Free: catalyst alerts, straight to your inbox.

Get the White House orders, federal contracts, and FDA decisions that move money — with who cashes in — free. Unsubscribe in one click.

Free · weekly · unsubscribe anytime. Privacy.

Stay three moves ahead of every practice in your market.

Knowing it happened is table stakes. Money Racket Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.

Get the edge · $40/mo

Join the owners who run ahead of the industry. Cancel anytime, one click.

Share

https://moneyracket.com/article/medicare-glp1-coverage-novo-eli-lilly-winners/

Discussion

    Leave a comment

    Comments are reviewed before they appear.
    Money Racket Pro

    By the time it's news, the money's already moved.

    The contract award, the executive order, the tariff cut — it mints winners before the financial press connects the dots. Pro gets you there first: what happened, who cashes in, and exactly what to watch — in a two-minute read.

    Go Pro · $40/mo The policy-to-profit brief. Cancel anytime.
    The pre-market brief · Mon–Sat, 7:45am ET Go Pro · $40/mo →